Effects of Wharton’s Jelly Mesenchymal Stem Cell-Derived Secretome on Cell Functions in Human Endometrium
Authors:
- Silviya DonevaSDSilviya Doneva
- Kalina BelemezovaKBKalina Belemezova
- Vesela StoychevaVSVesela Stoycheva
- Ivan BochevIBIvan Bochev
- Tanya TimevaTanya Timeva
- Maria YunakovaMYMaria Yunakova
- Petya AndreevaPAPetya Andreeva
- Katerina KavaldzhievaKKKaterina Kavaldzhieva
- Atanas ShterevASAtanas Shterev
- Stanimir KyurkchievSKStanimir Kyurkchiev
Open Access
Abstract
Background: Thin endometrium is a significant cause of infertility due to impaired regeneration, reduced receptivity, and insufficient angiogenesis. Mesenchymal stem cell-derived secretome (MSCsec) is a promising cell-free therapy because it contains bioactive molecules that promote tissue repair. This study evaluated the effects of Wharton’s jelly-derived MSC secretome (WJ-MSCsec) on human endometrial stromal cells (EnSCs) and endothelial cells in vitro. Methods: WJ-MSCs were isolated from umbilical cord tissue, characterized, and cultured under serum-free conditions. The concentrated secretome was analyzed using a human angiogenesis proteome array. EnSCs were isolated from endometrial biopsies. EnSC proliferation and migration in the presence of WJ-MSCsec were assessed using CCK-8 and scratch wound-healing assays. Pro-angiogenic activity of WJ-MSCsec was evaluated using a Matrigel tube formation assay with human umbilical vein endothelial cells (HUVECs). Results: Proteomic analysis of WJ-MSCsec revealed the presence of angiogenic, mitogenic, immunomodulatory, and chemotactic factors. Treatment with WJ-MSCsec significantly enhanced EnSC proliferation and accelerated wound closure. Furthermore, WJ-MSCsec markedly promoted endothelial tube formation, increasing total tube length, junction number, and mesh formation. Conclusions: WJ-MSCsec stimulates EnSC proliferation and migration while enhancing angiogenesis in vitro. WJ-MSCsec represents a promising cell-free therapeutic strategy for endometrial regeneration and reproductive disorders associated with impaired endometrial function.Keywords
This publication has 35 references indexed in Scilit:
- Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery methodExpert Opinion on Biological Therapy, 2021
- Angiogenesis Analyzer for ImageJ — A comparative morphometric analysis of “Endothelial Tube Formation Assay” and “Fibrin Bead Assay”Scientific Reports, 2020
- Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potentialnpj Regenerative Medicine, 2019
- Investigation of platelet‐rich plasma in increasing proliferation and migration of endometrial mesenchymal stem cells and improving pregnancy outcome of patients with thin endometriumJournal of Cellular Biochemistry, 2018
- Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertilityScience China Life Sciences, 2018
- Mesenchymal stem cell: An efficient mass producer of exosomes for drug deliveryAdvanced Drug Delivery Reviews, 2013
- Assessment of presence and characteristics of multipotent stromal cells in human endometrium and deciduaReproductive BioMedicine Online, 2010
- Characterization of mesenchymal stem cells isolated from the human umbilical cordCell Biology International, 2008
- Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen‐stimulated B‐cell immunoglobulin production in vitroCell Biology International, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006